MedPath

HAN-LINSPEC INJECTABLE SOLUTION

Registration Number: MAL24026027HA

Approved
Approval ID

901d9cca9c90a934

Registration Number

MAL24026027HA

Registration Date

Jul 4, 2025

Regulatory Authority
NPRA
Malaysia

Product Information

Additional product specifications and packaging information as registered with NPRA Malaysia.

Product Specifications

PRODUCT SPECIFICATIONS

Official SourceNPRA Database
Available Package Types1 type
Last UpdatedJul 4, 2025

PACKAGING INFORMATION (1)

100 mlAvailable
Package Size: 100 ml
Status: NPRA Approved

Active Ingredients

Active pharmaceutical ingredients contained in this NPRA-approved product.

Ingredients (2)

Spectinomycin Dihydrochloride PentahydrateActive
Monograph: spectinomycin dihydrochloride pentahydrate
Lincomycin HydrochlorideActive
Monograph: 林可霉素

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

HAN-LINSPEC INJECTABLE SOLUTION - NPRA Drug Approval Details | MedPath - Medical Intelligence Platform